Final answer:
An adequate therapy outcome for a patient receiving alteplase for an AMI is indicated by a reduction of ST-segment elevation on a 12-lead ECG, which signifies clot dissolution and restored blood flow.
Step-by-step explanation:
The client receiving the thrombolytic agent alteplase for treatment of an acute myocardial infarction (AMI) would indicate adequate therapy by a reduction of ST-segment elevation on a 12-lead ECG. The ST-segment elevation is commonly associated with damage to the heart muscle during an AMI, and its reduction is a sign that the alteplase is working to dissolve the clot and restore blood flow to the affected area of the heart. Although other outcomes such as absence of cardiac arrhythmias, stabilization of blood pressure, and cardiac enzymes within normal limits are also desirable, they may not be immediate indicators of the effectiveness of thrombolytic therapy.